A Canadian medical cannabis company has announced the launch of a high-potency cannabidiol (CBD) oil for patients.
Napanee, Ontario-based VIVO Cannabis Inc. on Tuesday announced the launch of CBD + | O oil under its Beacon Medical brand.
According to VIVO CBD + | O oil is a 2: 100 (THC: CBD) distillate-based cannabis oil with 100 mg of CBD and less than 2 mg of delta-9 tetrahydrocannabinol (THC).
VIVO says Beacon Medical formulates all of its cannabis oil products using a non-transgenic food grade medium chain triglyceride (MCT) carrier oil.
According to VIVO, the carrier oil results in a final product that has no smell or taste.
VIVO CEO Ray Laflamme says the company aspires to deliver premium cannabinoid-based medical products to patients through its commitment to the medical cannabis market.
“We recognize that many of our patients are looking for products that meet their individual needs,” says Laflamme. “And this latest addition to the Beacon Medical product family is an excellent high-potency CBD option for patients, and will be available to patients, doctors and hospitals alike.”
Laflamme says the release of Beacon Medical CBD + | O responds to patient opinions that the company team has collected over time.
VIVO has also launched the Pediatric Compassionate Care Program to support families and caregivers who need cannabis to treat various medical conditions.
According to VIVO, eligible patients will receive substantial discounts on all CBD products from Beacon Medical, Canna Farms, Fireside and Lumina.
He says ALIVE stays strong about his first patient approach to ensuring access, choice and a steady supply for patients with medical cannabis in Canada, Australia and Germany.
Beacon Medical CBD + | O’s new high-potency oil is available through Canna Farms ’ecommerce medical market for Canadian patients.
Patients who need registration or order support can get help from the VIVO customer service team by phone at 1-855-882-0988 or by email at care@vivocannabis.com.
31
